Clorox Positioned For Comeback: Analyst Predicts Earnings Beats And 3-Year Growth Surge, Upgrades Stock
1
0
Jefferies analyst Kaumil Gajrawala upgraded Clorox Company (NYSE:CLX) to Buy from Hold, raising the price forecast to $187 from $174.
The analyst projects that Clorox will return to its former status as a company delivering peer-leading economic profit growth and returns on capital.
Historically, this performance has warranted a valuation premium of 30% compared to its peers.
According to the analyst, topline growth is already showing signs of improvement, and operating leverage is becoming increasingly attainable.
Clorox has lagged behind its peers in growth reinvestments due to challenges such as COVID, supply chain issues, inflation, and cybersecurity from 2020 to 2024.
Also Read: Chinese EV …
Full story available on Benzinga.com
Visited 1 times, 1 visit(s) today